Skip to Content

Pfizer JKI 5 (Xeljanz 5 mg)

Generic Name: tofacitinib

Pill with imprint Pfizer JKI 5 is White, Round and has been identified as Xeljanz 5 mg. It is supplied by Pfizer, Inc..

Xeljanz is used in the treatment of rheumatoid arthritis; ulcerative colitis; psoriatic arthritis and belongs to the drug class antirheumatics. Risk cannot be ruled out during pregnancy. Xeljanz 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Pfizer JKI 5

Xeljanz

Generic Name:
tofacitinib
Imprint:
Pfizer JKI 5
Strength:
5 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Antirheumatics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Pfizer, Inc.
National Drug Code (NDC):
00069-1001

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide